Samsung Galaxy Watch 8 tested to detect GLP-1…

May 28, 2026

The Short Version

Samsung is testing Galaxy Watch 8's body composition sensor against clinical scans to detect muscle loss in people taking GLP-1 drugs like Ozempic.

Over 30% of weight lost on GLP-1 drugs like Ozempic can come from muscle, not fat, and Samsung is now testing whether the Galaxy Watch 8's body composition sensor can catch that loss as accurately as a clinical DXA scan. If the study holds up, a watch on your wrist does something a doctor's office visit currently handles. Samsung is not adding a wellness feature. It is auditing whether consumer hardware belongs in a medical conversation.

Dig Deeper

How Samsung and Apple Watch Are Replacing Your Doctor's Office

From predicting fainting five minutes early to catching heart conditions four times more often than a doctor visit, the wearable industry is stacking up clinical evidence fast. Blood sugar monitoring without a needle is still a few years out, but that future is looking more realistic each day.

Read the full story →

Also Worth Reading

Engadget

Samsung is testing Galaxy Watch 8 to prevent muscle loss on GLP-1s like Ozempic

Read →

Samsung Newsroom

Samsung and Massachusetts General Hospital Launch Joint Study To Investigate GLP-1 Treatment Monitoring With Galaxy Watch

Read →

SamMobile

New Galaxy Watch study to monitor muscle loss during GLP-1 therapy

Read →

Samsung Galaxy Watch 8 tested to detect GLP-1 muscle loss

Also Worth Reading